✦ LIBER ✦

EFFECT OF APIXABAN AN ORAL DIRECT AND SELECTIVE FACTOR XA INHIBITOR ON INFLAMMATORY BIOMARKERS FOLLOWING ACUTE CORONARY SYNDROME

✍ Scribed by Becker, Richard C.; Lin, Annie; Yang, Hongqiu; Barrett, Yuchen; Mohan, Puneet; Wang, Jessie; Alexander, John

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chromogenic laboratory assays to measure

✍ Richard C. Becker; Hongqiu Yang; Yuchen Barrett; Puneet Mohan; Jessie Wang; Lars 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 374 KB

The efficacy and safety of apixaban, an

✍ M. R. LASSEN; B. L. DAVIDSON; A. GALLUS; G. PINEO; J. ANSELL; D. DEITCHMAN 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB

Effect of hepatic impairment on the phar

✍ Kubitza, Dagmar; Roth, Angelika; Becka, Michael; Alatrach, Abir; Halabi, Atef; H 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB

RUBY-1: a randomized, double-blind, plac

✍ Steg, P. G.; Mehta, S. R.; Jukema, J. W.; Lip, G. Y. H.; Gibson, C. M.; Kovar, F 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 375 KB

The effects of warfarin and edoxaban, an

✍ Morishima, Yoshiyuki; Kamisato, Chikako; Honda, Yuko; Furugohri, Taketoshi; Shib 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 432 KB